FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging
Journal of Clinical Investigation · 17.02.2025 · 135 (4)
DOI: 10.1172/jci191424 ↗Kurz gefasst
Korrektur in der Zeitschrift Journal of Clinical Investigation, online erschienen am 17.02.2025. Verfasst von Hanjun Li und 14 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
. A hallmark of aged mesenchymal stem/progenitor cells (MSCs) in bone marrow is the pivot of differentiation potency from osteoblast to adipocyte coupled with a decrease in self-renewal capacity. However, how these cellular events are orchestrated in the aging progress is not fully understood. In this study, we have used molecular and genetic approaches to investigate the role of forkhead box P1 (FOXP1) in transcriptional control of MSC senescence. In bone marrow MSCs, FOXP1 expression levels declined with age in an inverse manner with those of the senescence marker p16 INK4A . Conditional depletion of Foxp1 in bone marrow MSCs led to premature aging characteristics, including increased bone marrow adiposity, decreased bone mass, and impaired MSC self-renewal capacity in mice. At the molecular level, FOXP1 regulated cell-fate choice of MSCs through interactions with the CEBPβ/δ complex and recombination signal binding protein for immunoglobulin κ J region (RBPjκ), key modulators of adipogenesis and osteogenesis, respectively. Loss of p16 INK4A in Foxp1 - deficient MSCs partially rescued the defects in replication capacity and bone mass accrual. Promoter occupancy analyses revealed that FOXP1 directly represses transcription of p16 INK4A . These results indicate that FOXP1 attenuates MSC senescence by orchestrating their […
Zitieren
APA
Li, H., Liu, P., Xu, S., Li, Y., Dekker, J. D., Li, B., Fan, Y., Zhang, Z., Hong, Y., Yang, G., Tang, T., Ren, Y., Tucker, H. O., Yao, Z., & Guo, X. (2025). FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging. Journal of Clinical Investigation, 135(4). https://doi.org/10.1172/jci191424
Vancouver
Li H, Liu P, Xu S, Li Y, Dekker JD, Li B, et al. FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging. Journal of Clinical Investigation. 2025;135(4). doi:10.1172/jci191424
BibTeX
@article{Li2025,
author = {Li, Hanjun and Liu, Pei and Xu, Shuqin and Li, Yinghua and Dekker, Joseph D and Li, Baojie and Fan, Ying and Zhang, Zhenlin and Hong, Yang and Yang, Gong and Tang, Tingting and Ren, Yongxin and Tucker, Haley O and Yao, Zhengju and Guo, Xizhi},
title = {FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {4},
doi = {10.1172/jci191424}
}
EUVIMED